Travere Therapeutics, Inc. — 424B5 Filings
16 424B5 filings on record
This page lists all 424B5 filings submitted to the SEC by Travere Therapeutics, Inc. (TVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Travere Therapeutics, Inc. has filed 16 424B5 documents with the SEC since 2014. To view all SEC filings by Travere Therapeutics, Inc., see the full filings list.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B3
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | 424B5 | 0001193125-24-254147 | Nov 8, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-253102 | Nov 7, 2024 | — |
| 424B5 | 424B5 | 0001438533-24-000050 | Oct 31, 2024 | — |
| 424B5 | 424B5 | 0001193125-23-056548 | Mar 1, 2023 | — |
| 424B5 | 424B5 | 0001193125-23-050949 | Feb 27, 2023 | — |
| 424B5 | 424B5 | 0001193125-22-070587 | Mar 9, 2022 | — |
| 424B5 | 424B5 | 0001193125-22-068713 | Mar 8, 2022 | — |
| 424B5 | 424B5 | 0001193125-21-041735 | Feb 12, 2021 | — |
| 424B5 | 424B5 | 0001193125-21-036369 | Feb 10, 2021 | — |
| 424B5 | 424B5 | 0001193125-20-164634 | Jun 9, 2020 | — |
| 424B5 | 424B5 | 0001193125-20-163477 | Jun 8, 2020 | — |
| 424B5 | 424B5 | 0001193125-20-046689 | Feb 24, 2020 | — |
| 424B5 | 424B5 | 0001193125-18-268237 | Sep 6, 2018 | — |
| 424B5 | 424B5 | 0001193125-18-266241 | Sep 4, 2018 | — |
| 424B5 | 424B5 | 0001193125-15-098742 | Mar 19, 2015 | — |
| 424B5 | 424B5 | 0001193125-15-094088 | Mar 16, 2015 | — |